Biotechnology News

June 25, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Appoints Dr. Soldano Ferrone to Scientific Advisory Board

June 25, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Elsevier announced its new Reference Module in Biomedical Sciences, which will provide biomedical and life science researchers access to reference content updated as science progresses.

June 25, 2014

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Orexo announces top-line data from a Phase 3 clinical trial demonstrating that Zubsolv® (buprenorphine/naloxone CIII sublingual tablet) is as effective as Suboxone® film in the treatment of...

June 24, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Phase 3 First-Line Melanoma Study of Nivolumab, an Investigational PD-1 Checkpoint Inhibitor, Demonstrates Superior Overall Survival Compared to Dacarbazine; Study Stopped Early

June 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the expansion of responsibilities for three members of its senior management team. The additional functional responsibilities, now at the senior...

June 24, 2014

CUPERTINO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (AFFY), a biopharmaceutical company, today announced that its Board of Directors has approved the liquidation and dissolution of the company, subject to stockholder approval, and plans to...

June 24, 2014

SAN DIEGO--(BUSINESS WIRE)--Today, California exiting senior Emily Wang won the International BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research in biotechnology. A panel of judges found...

June 24, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE MKT:ATNM), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced...

June 24, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. (NASDAQ: HRTX), a specialty pharmaceutical company, today announced its intention to offer and sell shares of its common stock in an underwritten offering pursuant to its existing...

June 24, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced that the company’s shares will be added to the Russell Microcap® Index following Russell Investments’ reconstitution of...

June 24, 2014

SAN DIEGO--(BUSINESS WIRE)--Day two of BIO 2014 in San Diego includes a keynote address with Sir Richard Branson, a session on new paradigms in oncology and the positive impact of the biotech industry on state economies.

June 24, 2014

SAN DIEGO--(BUSINESS WIRE)--The new Battelle/BIO State Bioscience Jobs, Investments and Innovation 2014 report reveals a robust bioscience sector that has weathered difficult economic conditions.

June 24, 2014

TORONTO--(BUSINESS WIRE)--Northleaf Venture Catalyst Fund commits $10 million, supporting continued Canadian expansion of Versant Ventures

June 24, 2014

SOLON, Ohio--(BUSINESS WIRE)--Multi Radiance Medical (MRM), manufacturer and marketer of FDA-cleared lasers for drug-free pain relief, congratulates the winners of the recent Professional Hockey and Basketball championships. “MRM technology is...

June 24, 2014

BLOOMINGTON, Ind. & GENEVA--(BUSINESS WIRE)--Cook Pharmica, LLC and Selexis SA Establish Customized Biologic Drug Development and Manufacturing Services Platform.

June 24, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--CORE Diagnostics, Inc., the leading high-end clinical diagnostics laboratory, announced today the appointment of K. Balachandran (Bala) as chief executive officer, effective immediately.

June 24, 2014

SAN DIEGO--(BUSINESS WIRE)--Eurobiomed and Biocom sign a cooperation agreement at the BIO International Convention in San Diego.

June 24, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, July 29, 2014. The purpose of the call is to provide an...

June 24, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck today announced that it has completed its acquisition of Chelsea Therapeutics International, Ltd.

June 24, 2014

MUNICH--(BUSINESS WIRE)--SIRION Biotech GmbH, a producer of multiple proprietary viral vector platforms participated on a panel at the Piper Jaffray GenomeRx Symposium on
Monday.

June 24, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”)(OTCBB:ACTC), a leader in the field of regenerative medicine, today announced the appointment of Paul Wotton, Ph.D., to the position of President and Chief Executive...

June 24, 2014

SAN DIEGO--(BUSINESS WIRE)--GenomeQuest Inc., a global provider of Intellectual Property search solutions for life science companies, today announced that its flagship software now includes a module for enabling customers to manage their...

June 24, 2014

SAN DIEGO--(BUSINESS WIRE)--Cardium announces positive interim phase 3 clinical data showing significant efficacy of Generx angiogenic gene therapy at the 2014 Bio International Convention.

June 24, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics, Inc. (NYSE:SFE) today announced that it will release its financial results for the second quarter 2014 prior to market open on Thursday, July 24, 2014.

June 24, 2014

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the resignation of Paul K. Wotton, Ph.D. who informed the Company’s Board of Directors that he will assume the position of chief executive officer of a development...

June 24, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Humacyte, Inc., a pioneer in regenerative medicine, has announced the completion of patient enrollment for two multi-center, investigative studies to assess the safety and efficacy of HumaGraft™, a...

June 24, 2014

LONDON, BOSTON, TOKYO & SAN DIEGO--(BUSINESS WIRE)--Record breaking new drug approvals, hefty product pipeline and dramatically improved R&D productivity prove that the industry is turning a new corner says "World Preview 2014, Outlook to...

June 24, 2014

ATLANTA--(BUSINESS WIRE)--Amniox Medical developer and marketer of restorative therapies processed from amniotic membrane and umbilical cord announces relocation of its corporate headquarters from Marietta, GA, to Atlanta, GA

June 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--DART Therapeutics, Inc. has changed its name to Akashi Therapeutics to reflect its progress in developing a pipeline of product candidates to improve the lives of children with DMD.

June 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis to present at two upcoming conferences on its program in DMD (Duchenne muscular dystrophy).

June 24, 2014

BERKELEY, Calif.--(BUSINESS WIRE)--U.S. Patent No. 8,758,286 issues to ExThera Medical, whose Seraph® technology is designed to
combat drug-resistant ‘superbugs’

June 24, 2014

DUBLIN--(BUSINESS WIRE)--Announcement under Irish Takeover Rules Relevant Securities in Issue – June 24, 2014

June 24, 2014

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--NeoChord appoints David Chung as President and CEO

June 24, 2014

KEARNEY, Neb.--(BUSINESS WIRE)--SCORR Marketing announces a new partnership with BioInformatics LLC, the premier research and advisory firm serving the life sciences industry.

June 24, 2014

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Expands Access to Clinical Trial Data Through Collaboration with Academic Research Institute

June 24, 2014

BOSTON--(BUSINESS WIRE)--Vital Healthcare Capital and Robert Wood Johnson Foundation announce a $10 million investment into Commonwealth Care Alliance's pioneering model of care.

June 24, 2014

SAN BRUNO, Calif.--(BUSINESS WIRE)--Numerate, Inc., which is applying novel machine-learning algorithms at cloud scale to transform small molecule drug discovery, today announced that it has completed an $8 million financing round.

June 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer

June 24, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, provided...

June 24, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep...

June 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced publication of an article titled “FAK Inhibitor Kills...

June 24, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company and the leader in the discovery of G protein coupled receptor (GPCR) biased ligands, today announced the publication of its Phase 1b...

June 24, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced the first treatment of a patient in Cologne,...

June 24, 2014

SAN DIEGO--(BUSINESS WIRE)--Organizations from Saskatchewan, Canada Showcase Award-Winning Research and Development at BIO International Convention – June 24-26 – San Diego, CA

June 24, 2014

SAN DIEGO--(BUSINESS WIRE)--AntiCancer Inc. has announced the development of new technology of combining fluorescence-guided surgery (FGS) of pancreatic cancer with ultraviolet light radiation to eliminate any residual cancer cells remaining...

June 24, 2014

LONDON--(BUSINESS WIRE)--Imperial College London is to study individuals with genetic mutations associated with Parkinson’s disease (PD) as one of 32 clinical sites of the PPMI study by The Michael J Fox Foundation.

June 24, 2014

SAINT-PREX & ROTKREUZ, Switzerland--(BUSINESS WIRE)--Ferring’s follicle-stimulating hormone is in development with a companion diagnostic test from Roche to help improve the clinical management of infertility treatment

June 24, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced the signing of an exclusive global license agreement with TG Therapeutics, Inc. (NASDAQ: TGTX) for the development and commercialization of Ligand’s...

June 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mersana and Merck KGaA have entered a collaboration to create antibody-drug conjugates using Mersana's Fleximer-ADC platform, which provides Merck KGaA the opportunity to expand its oncology pipeline.